Development and validation of a logistic regression model for predicting visual impairment in middle-aged and older adults with diabetes: results from the China Health and Retirement Longitudinal Study

建立和验证用于预测中老年糖尿病患者视力障碍的逻辑回归模型:来自中国健康与养老追踪研究的结果

阅读:1

Abstract

AIM: To develop and validate a clinician-friendly logistic regression prediction model for self-reported visual impairment (VI) in middle-aged and older adults (≥45y) with diabetes. METHODS: Leveraging data from the China Health and Retirement Longitudinal Study (CHARLS), a model for VI among adults aged ≥45y with diabetes were developed. Feature selection involved LASSO regression and subsequent multivariable logistic regression. Eight machine learning algorithms were explored and compared for predictive performance. Logistic regression for its consistent performance, interpretability, and clinical usability was finally selected. A nomogram and interactive web-based tool were constructed to facilitate application. RESULTS: Totally 1918 participants (45.83% males) in CHARLS 2011 with aged ≥45y were analyzed in the training cohort and 1553 in CHARLS 2015 were in validation cohort. Among all participants in the training cohort, 39.6% reported VI. Seven variables were found to be independently associated with VI. The optimal model, logistic regression model, achieved area under the curve (AUC) of 0.702 and 0.706 in the training and validation cohorts, respectively. The model's potential for clinical application was supported by calibration and decision-curve analyses; the resulting nomogram and web calculator provided individualized risk prediction. CONCLUSION: We developed a clinically interpretable logistic regression model to predict the risk of VI in adults aged ≥45y with diabetes. The accompanying nomogram and web tool may assist with early identification and targeted vision care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。